Core Viewpoint - Bragar Eagel & Squire, P.C. is investigating potential claims against Humana Inc. due to a class action lawsuit alleging breaches of fiduciary duties by the board of directors during the specified class period [2][4]. Group 1: Class Action Lawsuit Details - The class action lawsuit against Humana alleges that the company made false or misleading statements regarding its adjusted earnings-per-share, particularly downplaying the impact of increased medical costs from pent-up demand for healthcare services [4]. - On June 13, 2023, UnitedHealth Group Inc. reported higher outpatient care activity, which led to a significant drop of over 11% in Humana's stock price [5]. - Following a report on June 16, 2023, indicating higher than anticipated non-inpatient utilization trends, Humana's stock price fell again, reflecting investor concerns [6]. - On January 18, 2024, Humana disclosed an increase in its benefits expense ratio to approximately 91.4% for Q4 2023, resulting in a nearly 8% decline in stock price [7]. - The announcement of a loss of $4.42 per share for Q4 2023 on January 25, 2024, due to higher inpatient utilization and expected persistent medical costs, caused Humana's stock to drop nearly 12% [8]. Group 2: Company Overview - Humana is a health insurance company that provides medical benefit plans to its members [3].

Group 1 - The proposed merger agreement between Chart Industries and Baker Hughes involves Baker Hughes acquiring all outstanding shares of Chart Industries for $210 in cash per share [2] - Chart Industries has strong near-term earnings and revenue projections, with at least one equity analyst valuing the company at $250 per share, indicating the proposed buyout price may undervalue the company [2] - Johnson Fistel, PLLP has initiated an investigation into whether the board members of Chart Industries breached their fiduciary duties regarding the proposed sale [1] Group 2 - Johnson Fistel, PLLP is a nationally recognized shareholder rights law firm that represents individual and institutional investors in shareholder derivative and securities class action lawsuits [4] - The firm has been recognized as a top plaintiffs' securities law firm in the United States, having recovered approximately $90,725,000 for clients in cases where it served as lead or co-lead counsel [5]

Core Viewpoint - Bragar Eagel & Squire, P.C. is investigating potential claims against Skyworks Solutions, Inc. due to a class action complaint alleging breaches of fiduciary duties by the board of directors during the period from August 8, 2023, to February 5, 2025 [1][2]. Financial Performance - On February 5, 2025, Skyworks announced its financial results for Q1 of fiscal year 2025, providing lower-than-expected revenue guidance for Q2, attributing this to an intensified competitive landscape [3]. - Following the announcement, Skyworks' stock price plummeted from $87.08 per share to $65.60 per share, marking a decline of over 24% in just one day [3]. Legal Context - The class action complaint filed on March 3, 2025, claims that the defendants misled investors regarding Skyworks' expected revenue for fiscal year 2025, expressing confidence in the company's growth potential and mobile business expansion [2]. - The law firm is encouraging long-term stockholders who suffered losses to contact them for discussions regarding their legal rights [1][4].

Core Viewpoint - Bragar Eagel & Squire, P.C. is investigating potential claims against Krispy Kreme, Inc. due to a class action lawsuit alleging breaches of fiduciary duties by the board of directors during a specified class period [1][2]. Group 1: Class Action Lawsuit Details - The class action lawsuit claims that Krispy Kreme made false or misleading statements regarding the demand for its products at McDonald's locations, which significantly declined after the initial marketing launch [2]. - It is alleged that the declining demand at McDonald's contributed to a decrease in average sales per door per week and that the partnership with McDonald's was not profitable, posing risks to the continuation of this partnership [2]. - The lawsuit also states that Krispy Kreme would pause its expansion into new McDonald's locations due to these issues [2]. Group 2: Financial Performance - On May 8, 2025, Krispy Kreme reported its first quarter 2025 financial results, revealing net revenue of $375.2 million, a decline of 15.3% compared to the previous year [3]. - The company also reported a net loss of $33.4 million, a significant increase from the prior year's net loss of $6.7 million [3]. - Following the release of these financial results, Krispy Kreme announced it would reassess its deployment schedule with McDonald's and withdrew its prior full-year outlook, citing uncertainty around the McDonald's deployment schedule [3]. - The announcement led to a nearly 25% drop in Krispy Kreme's share price [3].

Core Viewpoint - Bragar Eagel & Squire, P.C. is investigating potential claims against Elevance Health, Inc. due to a class action lawsuit alleging that the company misled investors regarding the impact of Medicaid redetermination on its financial guidance and cost trends [1][2]. Group 1: Legal Investigation - The law firm is representing long-term stockholders of Elevance who held shares between April 18, 2024, and October 16, 2024, following a class action complaint filed on May 12, 2025 [1]. - The investigation focuses on whether Elevance's board of directors breached their fiduciary duties to the company [1]. Group 2: Allegations in the Lawsuit - The lawsuit claims that Elevance made false or misleading statements about its monitoring of cost trends related to the Medicaid redetermination process [2]. - It is alleged that while Elevance acknowledged rising Medicaid expenses, it misrepresented that these were adequately reflected in its financial guidance for 2024 [2]. - The lawsuit highlights that the redetermination process led to a significant increase in the acuity and utilization of Medicaid members, contrary to the company's assurances [2]. Group 3: Contact Information - Investors seeking more information or wishing to discuss their rights can contact Brandon Walker or Marion Passmore at Bragar Eagel & Squire, P.C. via phone or email [3][6].

SAN DIEGO, July 10, 2025 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, PLLP has launched an investigation into whether the board members of WK Kellogg Co (NYSE: KLG) breached their fiduciary duties in connection with the proposed sale of the Company to Ferrero. On July 10, 2025, WK Kellogg Company entered into a definitive agreement with Ferrero pursuant to which Ferrero will acquire all of the outstanding shares of the Company in a go‐private transaction for $23.00 in cash per share—a pri ...

Core Viewpoint - Bragar Eagel & Squire, P.C. is investigating potential claims against Compass Diversified due to a class action lawsuit alleging breaches of fiduciary duties by the company's board of directors during a specified class period [1][2]. Summary by Relevant Sections Lawsuit Details - The class action complaint was filed on June 6, 2025, covering a class period from May 1, 2024, to May 7, 2025 [1]. - Allegations include that Compass's subsidiary, Lugano Holdings, Inc., had unrecorded financing arrangements and irregularities in its financial reporting, which affected the reliability of the company's overall financial statements [2]. - The lawsuit claims that the company failed to maintain adequate internal controls over its financial statements, leading to materially false and misleading public statements [2]. Investor Information - Long-term stockholders of Compass are encouraged to reach out for more information regarding the claims or their rights related to the lawsuit [3].

Core Viewpoint - Johnson Fistel, PLLP has initiated an investigation into DexCom, Inc. for potential breaches of fiduciary duties and violations of federal securities laws due to misleading public statements made by certain insiders regarding the company's expansion strategy and market share [1][2]. Summary by Relevant Sections Investigation Details - The investigation focuses on actions taken by DexCom insiders between April 28, 2023, and June 5, 2024, which led to the issuance of false and misleading statements about the company's growth and market position [2]. - DexCom began making corrective disclosures starting April 25, 2024, revealing that its growth and business prospects were significantly lower than previously claimed [2]. - By the final corrective disclosure on July 25, 2024, DexCom's share price had decreased by over 40.6% [2]. Shareholder Rights - Current stockholders who held DexCom stock before April 28, 2023, are encouraged to contact Johnson Fistel to discuss their legal rights regarding the investigation [3].

Group 1 - Johnson Fistel, PLLP is investigating potential breaches of fiduciary duties by current and former directors and officers of Masimo Corporation, focusing on their responsibilities to shareholders and corporate governance obligations [1] - The investigation follows a court ruling from November 5, 2024, which allowed certain claims in a shareholder class action lawsuit to proceed, alleging that Masimo misrepresented the financial performance of Sound United and misled investors about the integration process [2] - Current or long-term shareholders of Masimo Corporation may have legal claims that could be pursued against its leadership to protect and recover shareholder value [3] Group 2 - Johnson Fistel, PLLP is a nationally recognized shareholder rights and securities litigation firm, representing both individual and institutional investors across multiple states [4]

Core Viewpoint - Bragar Eagel & Squire, P.C. is investigating potential claims against Avis Budget Group, Inc. due to a class action complaint alleging breaches of fiduciary duties by the board of directors [1][2]. Summary by Relevant Sections Lawsuit Allegations - The lawsuit claims that Avis Budget made materially false and misleading statements and failed to disclose adverse information regarding its business and operations [2]. - Specific allegations include: - Avis Budget implemented a plan to significantly accelerate fleet rotation in Q4 2024 [2]. - This acceleration shortened the useful life of most vehicles in the Americas segment, reducing their recoverable value [2]. - As a result, Avis Budget would need to recognize billions of dollars in impairment charges and incur substantial losses [2]. - The aforementioned actions had a significant negative impact on the company's financial results [2]. - Consequently, Avis Budget's financial and business prospects were overstated [2]. Contact Information - Long-term stockholders of Avis who have information or questions regarding the claims can contact Bragar Eagel & Squire, P.C. via email or phone [3][6].